230 likes | 332 Views
Impact of DNA Repair Mechanisms on Resistance to alkylating therapeutic agents. NH 2. NH 2. C. O. C. O. N. N. N. N. N. N. CH 3. CH 3. N. NH 2. N. N. H. O. C. O. N. N. N. N. CH 3. CH 3. N. TMZ. MTIC. DITC. NH 2. CH 3. O. C. O. N. N. N. N. N. H 2 N. N.
E N D
Impact of DNA Repair Mechanisms on Resistance to alkylating therapeutic agents
NH2 NH2 C O C O N N N N N N CH3 CH3 N NH2 N N H O C O N N N N CH3 CH3 N TMZ MTIC DITC
NH2 CH3 O C O N N N N N H2N N CH3 N N H TMZ O6mG CH3 O N MTIC N H2N N N N7mG
Repair Pathways Responsible for Processing Methyl DNA Adducts TMZ MGMT & MMR O6mG (6%) N7mG (70%) N3mA (9%) BER
The Correlation of MGMT Activity to the Drug Resistance 1500 100 10 1 0.1 0 1000 Tumor Volume (mm3) BCNU 30 mg/kg 500 0 0 10 20 30 40 50 60 Days 0.1 % 1 % 10 % 100 % Cancer Res. 1997
MGMT MGMT O Cys Cys N HN S S H2N N N Reaction of O6-benzylguanine and AGT Protein - O N N H2N N N O6-benzylguanine (BG) Guanine
AGT AGT O6-Methylating Agent MGMT Repair Mismatch Repair Cytotoxicity Cell Survival
Resistance of MMR Deficient Colon Cancer Cells to TMZ SW480 (MMR+) HCT 15 (MSH6 mut) HCT 116 (MLH1 mut) 100 100 100 +BG +BG 10 10 10 +BG 1 1 1 0 500 1000 1500 2000 0 500 1000 1500 2000 0 500 1000 1500 2000 TMZ(µM) Cancer Res. 1996
Repair Pathways Responsible for Processing Methyl DNA Adducts TMZ MGMT & MMR O6mG (6%) N7mG (70%) N3mA (9%) BER
MPG Methoxyamine XRCC1 PARP b DNA pol XRCC1 XRCC1 LigaseIII BER pathway N7mG AP site APE
5’ P P P 3’ O C H 5’ 5’ P P P P P P 3’ 3’ O CH3 HN H HO C Methoxyamine binds to aldehyde group in an AP site MPG MX APE
U UDG MX NHOCH3 MX bound AP Site is Resistant to Cleavage by AP-endonuclease + - + - APE AP site 40 mer 20 mer AP-MX site AP-MX Site AP Site
5’ 5’ OH OH O NH-O- CH3 CH3 O N 3’ 3’ AP site AP site-MX 6 5 4 Unit of Density 3 2 2 1 r = 0.993 0 0 0.375 0.75 1.5 3 6 AP-DNA substrate (g) 5’ 5’ O H OH OH Strepta.HRP N O Strep HRP N NH2 O O N O H 3’ 3’ AP site-ARP AP site
Control TMZ (175µM) TMZ (175µM)+MX(25 mM) TMZ (350µM) 10 TMZ (350µM)+MX(25 mM) 7.5 TMZ (750µM) 5 TMZ (750µM)+MX(25 mM) 2.5 r = 0.995 0 0 94 187 375 750 1500 TMZ(µM) T T M M Z Z 1 1 4 4 T T M M Z Z + + M M X X 1 1 2 2 1 1 0 0 MX-AP 8 8 6 6 4 4 2 2 0 0 0 0 1 1 8 8 7 7 3 3 7 7 5 5 7 7 5 5 0 0 1 1 5 5 0 0 0 0 T T M M Z Z ( ( u u M M ) ) AP sites (unit of density)
Methoxyamine Interrupt BER Pathway MX APE O CH3 HN H HO C 5’ P P P 3’ Block DNA Synthesis Chromosomal Aberration Apoptosis Cell Death
SW480 Tumor Growth in Nude Mice Clin. Cancer Res. 2002
Inhibition of SW480 Tumor Growth By BG plus MX and TMZ in Nude Mice
HCT116 Tumor Growth in Nude Mice 2000 Control TMZ (120 mg/kg) 1500 BG (30 mg/kg)+TMZ MX (0.2 mg/kg) 1000 MX+TMZ 500 0 0 5 10 15 20 25 30 Days
Compared to TMZ alone, the combination of MX+TMZ has No additive toxicity, Compared to BG+TMZ, the combination of MX+TMZ has No toxic death Less body weight loss Less myelosuppression
Blocking BER efficiently potentiate TMZ-antitumor Effect bypassing MMR and p53 genetic status.